SG11201609837WA - Pharmaceutical composition comprising pyrazine carboxamide compound as active ingredient - Google Patents

Pharmaceutical composition comprising pyrazine carboxamide compound as active ingredient

Info

Publication number
SG11201609837WA
SG11201609837WA SG11201609837WA SG11201609837WA SG11201609837WA SG 11201609837W A SG11201609837W A SG 11201609837WA SG 11201609837W A SG11201609837W A SG 11201609837WA SG 11201609837W A SG11201609837W A SG 11201609837WA SG 11201609837W A SG11201609837W A SG 11201609837WA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
active ingredient
carboxamide compound
pyrazine carboxamide
pyrazine
Prior art date
Application number
SG11201609837WA
Other languages
English (en)
Inventor
Satoshi Konagai
Hiroaki Tanaka
Hiroko Yamamoto
Hideki Sakagami
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of SG11201609837WA publication Critical patent/SG11201609837WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
SG11201609837WA 2014-05-28 2015-05-27 Pharmaceutical composition comprising pyrazine carboxamide compound as active ingredient SG11201609837WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014109952 2014-05-28
PCT/JP2015/065154 WO2015182628A1 (ja) 2014-05-28 2015-05-27 ピラジンカルボキサミド化合物を有効成分とする医薬組成物

Publications (1)

Publication Number Publication Date
SG11201609837WA true SG11201609837WA (en) 2016-12-29

Family

ID=54698952

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201609837WA SG11201609837WA (en) 2014-05-28 2015-05-27 Pharmaceutical composition comprising pyrazine carboxamide compound as active ingredient

Country Status (15)

Country Link
US (1) US20170196859A1 (ja)
EP (1) EP3150206A1 (ja)
JP (1) JPWO2015182628A1 (ja)
KR (1) KR20170005820A (ja)
CN (1) CN106456636A (ja)
AU (1) AU2015266552A1 (ja)
CA (1) CA2949028A1 (ja)
EA (1) EA201692479A1 (ja)
IL (1) IL249010A0 (ja)
MA (1) MA39908A (ja)
MX (1) MX2016015551A (ja)
PH (1) PH12016502313A1 (ja)
SG (1) SG11201609837WA (ja)
TW (1) TW201625254A (ja)
WO (1) WO2015182628A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3290036A4 (en) * 2015-04-27 2019-01-02 Astellas Pharma Inc. Stabilized pharmaceutical composition
JP2019014653A (ja) * 2015-11-27 2019-01-31 アステラス製薬株式会社 がん免疫を介したがん治療方法
US20190282569A1 (en) * 2016-10-26 2019-09-19 Astellas Pharma Inc. Stable pharmaceutical composition
WO2023129667A1 (en) 2021-12-30 2023-07-06 Biomea Fusion, Inc. Pyrazine compounds as inhibitors of flt3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110025224A (ko) * 2008-06-27 2011-03-09 아빌라 테라퓨틱스, 인크. 헤테로아릴 화합물 및 이의 용도
NZ627709A (en) * 2010-06-23 2014-12-24 Hanmi Science Co Ltd Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity
RS55704B1 (sr) * 2012-01-17 2017-07-31 Astellas Pharma Inc Jedinjenje pirazin karboksamida

Also Published As

Publication number Publication date
PH12016502313A1 (en) 2017-02-13
TW201625254A (zh) 2016-07-16
US20170196859A1 (en) 2017-07-13
MA39908A (fr) 2015-12-03
IL249010A0 (en) 2017-01-31
CA2949028A1 (en) 2015-12-03
WO2015182628A1 (ja) 2015-12-03
EA201692479A1 (ru) 2017-03-31
AU2015266552A1 (en) 2016-12-01
EP3150206A1 (en) 2017-04-05
CN106456636A (zh) 2017-02-22
KR20170005820A (ko) 2017-01-16
MX2016015551A (es) 2017-03-23
JPWO2015182628A1 (ja) 2017-04-20

Similar Documents

Publication Publication Date Title
HK1219432A1 (zh) 以嘧啶化合物爲有效成分的醫藥組合物
PT3116491T (pt) Composições farmacêuticas de compostos terapeuticamente ativos
ZA201605379B (en) Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient
HK1254573A1 (zh) 包含苯基氨基嘧啶衍生物的藥物組合物
PT3202759T (pt) Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo
IL304109A (en) Pharmaceutical preparations containing spinamide
HK1243927A1 (zh) 含有茶皂醇衍生物作爲活性成分的組合物
IL249010A0 (en) A pharmaceutical preparation containing a pyrazine carboxamide compound as an active ingredient
SG11201608845PA (en) Cosmetic composition containing mentha haplocalyx as active ingredient
IL252663A0 (en) A pharmaceutical preparation containing an aromatic heterocyclic amide compound containing nitrogen as an active ingredient
EP3120848A4 (en) Therapeutic/preventive agent containing coumarin derivative as active ingredient
IL252664A0 (en) A pharmaceutical preparation containing an aromatic heterocyclic amide compound containing nitrogen as an active ingredient
HUE058886T2 (hu) Safinamidot tartalmazó gyógyászati készítmények